echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > 2013 Meihua Group Annual Report: Net profit of 404 million amino acid unit price decline

    2013 Meihua Group Annual Report: Net profit of 404 million amino acid unit price decline

    • Last Update: 2020-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , March 7, Meihua Group (600873) released its 2013 annual report on Friday evening, showing that the company achieved a net profit of 404 million yuan last year, down 33.58 percent year-on-yearTBV
    The report shows that in 2013, the company achieved operating income of RMB7.780 billion, up 4.16% YoY, and earnings per share of RMB0.13, down 40.91% YoYTBV
    Meihua Group said that during the reporting period, the company's operating income increased slightly year-on-year, including the domestic market revenue of 5.340 billion yuan, down 7.92% YoY, and the international market revenue of 2.440 billion yuan, up 46.09 percent Year-on-yearThe most important driver of business revenue growth is product sales growthHowever, due to weak market demand and lower product prices, net profit attributable to the company's owners decreased year-on-year during the reporting periodTBV
    The company said that large varieties of amino acid sales, the company firmly implement b2B industrial products sales strategy, continue to expand production capacity, to maintain industry leadershipDuring the reporting period, sucone and lysine accounted for 21% of total operating incomeDue to the partial release of new production capacity in Xinjiang, during the reporting period, the production of Susine increased by 27,000 tons compared to 2012, affected by the external environment and market demand, the price of Susine has been down since January 2013, after falling to the bottom in June 2013 has rebounded slightly, and is currently maintaining a volatile upward trend, the market is expected to be slightly better than 2013Compared with 2012, the average sales price of susine decreased by about 746 yuan per ton, and the gross margin decreased from 25.93% to 14.67%During the reporting period, in order to broaden the product sales channels, the company began mass production in February 70% content of lysine, the annual sales of 70% of the content of lysine up to 44,000 tonsRevenue growth from increased production was not sufficient to offset the decrease in operating profit due to a significant decline in unit prices, with the 98% level lysine being 34 percentage points lower in 2013 compared to 2012TBV
    In terms of amino acids of small varieties, the unit price of glutamine is high and the gross margin is highDuring the reporting period, the price of the product declined by a large margin, the average price decreased by 44,000 yuan compared to 2012, the gross profit margin of the product decreased by about 27 percentage points year-on-year, although the sales volume increased by 1100 tons, but the sales revenue did not increase and decreased by 2.96 million yuanDuring the reporting period, the overall price performance of isoline was better than glutamine, after the price fell to the bottom in March, showed an arc rebound trend, in October after a sharp pull-up of the V-type rational return to decline, but the overall average price is still 25% lower than in 2012, gross margin decreased by 12.26% YoYTBVMarch 7, Meihua Group (600873) released its 2013 annual report on Friday night, showing that the company achieved a net profit of 404 million yuan last year, down 33.58 percent year-on-yearTBV
    The report shows that in 2013, the company achieved operating income of RMB7.780 billion, up 4.16% YoY, and earnings per share of RMB0.13, down 40.91% YoYTBV
    Meihua Group said that during the reporting period, the company's operating income increased slightly year-on-year, including the domestic market revenue of 5.340 billion yuan, down 7.92% YoY, and the international market revenue of 2.440 billion yuan, up 46.09 percent Year-on-yearThe most important driver of business revenue growth is product sales growthHowever, due to weak market demand and lower product prices, net profit attributable to the company's owners decreased year-on-year during the reporting periodTBV
      The company said that large varieties of amino acid sales, the company firmly implement b2B industrial products sales strategy, continue to expand production capacity, to maintain industry leadership During the reporting period, sucone and lysine accounted for 21% of total operating income Due to the partial release of new production capacity in Xinjiang, during the reporting period, the production of Susine increased by 27,000 tons compared to 2012, affected by the external environment and market demand, the price of Susine has been down since January 2013, after falling to the bottom in June 2013 has rebounded slightly, and is currently maintaining a volatile upward trend, the market is expected to be slightly better than 2013 Compared with 2012, the average sales price of susine decreased by about 746 yuan per ton, and the gross margin decreased from 25.93% to 14.67% During the reporting period, in order to broaden the product sales channels, the company began mass production in February 70% content of lysine, the annual sales of 70% of the content of lysine up to 44,000 tons Revenue growth from increased production was not sufficient to offset the decrease in operating profit due to a significant decline in unit prices, with the 98% level lysine being 34 percentage points lower in 2013 compared to 2012 TBV
      In terms of amino acids of small varieties, the unit price of glutamine is high and the gross margin is high During the reporting period, the price of the product declined by a large margin, the average price decreased by 44,000 yuan compared to 2012, the gross profit margin of the product decreased by about 27 percentage points year-on-year, although the sales volume increased by 1100 tons, but the sales revenue did not increase and decreased by 2.96 million yuan During the reporting period, the overall price performance of isoline was better than glutamine, after the price fell to the bottom in March, showed an arc rebound trend, in October after a sharp pull-up of the V-type rational return to decline, but the overall average price is still 25% lower than in 2012, gross margin decreased by 12.26% YoY TBV
    Share it on feed
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.